New Research Reveals Importance Of Anti-Mullerian Hormone
Monday, October 17, 2023 4:14 PM CT
Highlights From the American Society For Reproductive Medicine’s 2023 Scientific Congress
New Orleans, LA – Research presented at the American Society for Reproductive Medicine (ASRM) Scientific Congress pointed out the important role that anti-Mullerian hormone (AMH) plays not just in fertility but in other areas of health as well.
Researchers from Ovation Fertility and others examined the relationship between AMH and the results of assisted reproductive technology (ART) treatments. This study examined over 800 ART cycles from 3 different locations. Their work found a very significant difference between patients with an AMH value of less than one and those with higher scores. The Higher AMD groups had higher numbers of eggs retrieved and a higher number of healthy embryos going to the blastocyst stage.
A group out of Scotland looked at the impact of AMH with natural conception. Analyzing data from over 3000 women trying to conceive but not undergoing fertility treatment. Using home-based tests to measure hormone levels, including AMH, they found that lower AMH levels were associated with a reduced chance of natural conception.
Finally, a Boston-based team looked at AMH levels beyond just reproductive capacity. Their work utilized a database that followed nearly 500 women for over a decade. Measuring blood hormone levels in 2003-2006 and Bone Density measures in 2017-2021. They found that higher AMH levels during reproductive years were associated with higher Bone Mineral Density and lower bone turnover markers measured later.
“These kinds of studies are extremely valuable as we continue to learn more about the role of AMH not just in reproduction, but throughout a woman’s life.” Said Steve Young, MD, President of the Society for Reproductive Endocrinology and Infertility.
- O-9 Sun et al “Low Anti-Mullerian Hormone Significantly related to low number of total blastocysts and Euploid Blastocyst Development”\
- O-82 Nelson et al “Anti-Mullerian Hormone levels are associated with chance of natural conception”
- O-185 Associations of Anti-Mullerian Hormone in Mid-reproductive years with bone mineral density and bone turnover markers during midlife: a longitudinal study.
To view these abstracts and more in full, please visit: https://www.fertstert.org/issue/S0015-0282(23)X0012-0
For almost a century, the American Society for Reproductive Medicine (ASRM) has been the global leader in multidisciplinary reproductive medicine research, ethical practice, and education. ASRM impacts reproductive care and science worldwide by creating funding opportunities for advancing reproduction research and discovery, by providing evidence-based education and public health information, and by advocating for reproductive health care professionals and the patients they serve. With members in more than 100 countries, the Society is headquartered in Washington, DC, with additional operations in Birmingham, AL. www.asrm.org
For media inquiries regarding this press release contact:
Sean Tipton
ASRM Chief Advocacy and Policy Officer
E: stipton@asrm.org
J. Benjamin Younger Office of Public Affairs
726 7th St. SE
Washington, DC 20003
Tel: (202) 863-2494
Fertility in the News

Doctors Group Launches Ad Campaign for Ohio Issue 1
ASRM announced the launch of an ad campaign throughout Ohio urging voters to select “Yes on Issue 1” when they head to the polls on November 7.

Dr. Paula Amato Sworn In As President Of The American Society For Reproductive Medicine
New Vice President and Board Members Announced
New Data Shows The Association Between Air Pollution And Miscarriage Risk
Research presented at ASRM 2023 examines the association between ambient air pollution and miscarriage.

New Research Focuses On The Need For DEI In Reproductive Medicine
New research delves into the challenges faced by underrepresented populations in accessing reproductive healthcare.
Infertility
Find a Health Professional
